Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 613 | 691 | 726 | 929 | 1,040 |
| Cost of Goods | 266 | 403 | 346 | 394 | 542 |
| Gross Profit | 348 | 289 | 380 | 534 | 498 |
| Operating Expenses | 2,839 | 2,404 | 2,549 | 3,555 | 3,372 |
| Operating Income | -2,226 | -1,713 | -1,823 | -2,626 | -2,332 |
| Interest Expense | 22 | 1 | 78 | 26 | 357 |
| Other Income | 29 | 23 | 7 | -134 | -20,656 |
| Pre-tax Income | -2,219 | -1,691 | -1,894 | -2,786 | -23,345 |
| Net Income Continuous | -2,219 | -1,691 | -1,894 | -2,786 | -23,345 |
| Net Income | $-2,219 | $-1,691 | $-1,894 | $-2,786 | $-23,345 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.07 | -0.21 | -1.40 |
| EPS Basic Continuous Ops | -0.06 | -0.04 | -0.07 | -0.21 | -1.40 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.07 | -0.21 | -1.40 |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | -0.07 | -0.21 | -1.40 |
| EBITDA(a) | $-2,044 | $-1,521 | $-1,598 | $-2,366 | $-2,127 |